Identification of Primary and Metastatic Lung Cancer-Related LncRNAs and Potential Targeted Drugs Based on CeRNA Network
Overview
Authors
Affiliations
Lung cancer metastasis is the leading cause of poor prognosis and death for patients. Long noncoding RNAs (lncRNAs) have been validated the close correlation with lung cancer metastasis, but few comprehensive analyses have reported the specific association between lncRNA and cancer metastasis, especially both competing endogenous RNA (ceRNA) regulatory relationships and functional regulatory networks. Here, we constructed primary and metastatic ceRNA networks, identified 12 and 3 candidate lncRNAs for lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) respectively and excavated some drugs that might have potential therapeutic effects on lung cancer progression. In summary, this study systematically analyzed the competitive relationships and regulatory mechanism of the repeatedly dysregulated lncRNAs in lung cancer carcinogenesis and metastasis, and provided a new idea for screening potential therapeutic drugs for lung cancer.
Zhu W, Zhang H, Tang L, Fang K, Lin N, Huang Y Clin Respir J. 2024; 18(10):e70026.
PMID: 39428538 PMC: 11491303. DOI: 10.1111/crj.70026.
High SNRPA1 expression leads to poor prognosis in patients with lung adenocarcinoma.
Yang J, Yang Y, Gu Y, Tong L, Liu Y, Zhang J Clin Respir J. 2023; 17(8):719-732.
PMID: 37277111 PMC: 10435942. DOI: 10.1111/crj.13647.
Grandt C, Brackmann L, Poplawski A, Schwarz H, Marini F, Hankeln T Front Oncol. 2023; 13:1158176.
PMID: 37182169 PMC: 10174438. DOI: 10.3389/fonc.2023.1158176.
Yang Y, Zhang S, Guo L Front Oncol. 2022; 12:807367.
PMID: 35186743 PMC: 8853726. DOI: 10.3389/fonc.2022.807367.
Weng C, Wang L, Liu G, Guan M, Lu L Front Oncol. 2021; 11:763027.
PMID: 34868980 PMC: 8637334. DOI: 10.3389/fonc.2021.763027.